Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 would would +6.86%
#4 Hive Hive +6.25%
#5 WAX WAX +5.69%
#6 Pons Pons +4.94%
#7 The Bitcoin Bull The Bitcoin Bull +4.43%
#8 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#9 edgeX edgeX +3.72%
#10 Ribbita by Virtuals Ribbita by Virtuals +3.31%
Coin of the day
Palladium Network Palladium Network
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Classificação em ações #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Preço da ação
$5.84
Última sincronização: 2025-04-02
Valor de mercado
$224.09M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Nevro Corp. (NVRO)

Categoria

Healthcare
Lucros da Nevro Corp. (NVRO)
Lucros em Dec 2024 TTM: $-112.35M
De acordo com os últimos relatórios financeiros da Nevro Corp., os ganhos atuais da empresa são de $-112.35M. Em 2023, a empresa teve ganhos de $-97.86M, uma diminuição em relação a aos ganhos de 2022, que foram de $4.26M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Nevro Corp. de 2012 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-112.35M 0.00%
2024 $-112.35M 14.80%
2023 $-97.86M -2,395.00%
2022 $4.26M -103.26%
2021 $-130.83M 59.16%
2020 $-82.20M -19.48%
2019 $-102.09M 110.76%
2018 $-48.44M 37.41%
2017 $-35.25M 16.90%
2016 $-30.16M -54.49%
2015 $-66.27M 119.41%
2014 $-30.20M 17.74%
2013 $-25.65M 36.41%
2012 $-18.81M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -6,785.60%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -4,682.27%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -5,051.67%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -3,536.70%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -1,361.82%
US